ABAX Abaxis, Inc. (delisted)

ABAXIS Announces Sponsorship of a Post-Graduate Veterinary Avian-Exotic Externship Program ABAXIS Partners with Avian & Exotic Animal Medical Center to Provide Specialized Professional Training UNION CITY, Calif., Nov. 10 /PRNewswire-FirstCall/ -- ABAXIS, Inc. , a medical products company manufacturing point-of-care blood analysis systems, announced partnership with Avian & Exotic Animal Medical Center of Miami, FL to provide a three month immersion course for veterinarians in all aspects of avian and exotic veterinary medicine and surgery. "The VetScan externship program will offer a selected veterinarian the unique hands-on opportunity to become proficient in the latest diagnostic and therapeutic techniques for birds and other exotic species. These animals represent the largest growth segment of the pet population in the United States, and as such we believe the program will be in high demand from veterinarians desiring to enhance their skills in a state-of-the-art facility," stated Pam Conboy, Abaxis Director of Marketing for Veterinary Medicine. Dr. Don Harris, clinic owner and collaborator on the project, states, "Avian & Exotic Animal Medical Center can provide a unique learning opportunity in one of the world's foremost exotic veterinary practices. Our staff has achieved international recognition for a progressive approach to veterinary care of exotic pets and our practical approach to teaching. This educational experience will allow practitioners the ability to learn in the most ideal of venues -- the actual clinical setting." Dr. Harris further adds, "We are pleased to partner with Abaxis on this project and we see it as further evidence of their commitment to the growing interest in this specialized branch of veterinary medicine." ABAXIS develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 6.9 kilogram, portable analyzer and a series of 8-cm diameter single-use plastic disks, called reagent discs, which contain all the reagents necessary to perform a fixed menu of tests. The system can be operated with minimal training and perform multiple tests on whole blood, serum, or plasma. The system provides test results in less than 14 minutes with the precision and accuracy equivalent to a clinical laboratory. This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. ABAXIS claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. Specific forward-looking statements contained in this press release include, but are not limited to, risks and uncertainties related to the market acceptance of the ABAXIS' products and the continuing development of its products, risks associated with manufacturing and distributing its products on a commercial scale, risks associated with entering the human diagnostic market on a larger scale, risks involved in carrying of inventory, risks associated with the ability to attract and retain competent sales personnel, general market conditions, competition, risks and uncertainties related to its ability to raise capital in order to fund its operations and other risks detailed from time to time in ABAXIS' periodic reports filed with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statement was made. ABAXIS does not undertake and specifically disclaims any obligation to update any forward-looking statements. DATASOURCE: ABAXIS, Inc. CONTACT: Clint Severson, Chief Executive Officer, ABAXIS, Inc., +1-510-675-6501; or Retail, Joe Dorame, or Institutional/Analysts/Media, Joe Diaz, both of RCG Capital Markets Group, +1-480-675-0400, for ABAXIS, Inc. Web site: http://www.abaxis.com/

Copyright